RHOKYRO
DEAD

Serial Number

88401758

Owner

Kadmon Pharmaceuticals, LLC

Attorney

Michael J. Leonard

Filing Date

Apr 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RHOKYRO Trademark

Serial Number: 88401758

RHOKYRO is a trademark filed by Kadmon Pharmaceuticals, LLC on April 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Kadmon Pharmaceuticals, LLC (28 trademarks)

400 Madison Avenue
New York, NY 10017

Entity Type: 16

Trademark Details

Filing Date

April 25, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 18, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 18, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2020 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 25, 2020 RCCK
ASSIGNED TO LIE
Aug 21, 2020 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2019 NWOS
NEW APPLICATION ENTERED
Apr 29, 2019 NWAP